Home The Word Brain My Amedeo FAQ Privacy About   


CC Journal Club

Our weekly journal club for junior residents and medical students


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    February 2025
  1. MEAIDI A, Yonis H
    Research on hormonal contraceptives is needed to monitor their evolving safety profile.
    BMJ. 2025;388:r341.
    PubMed    


  2. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    PubMed     Abstract available


  3. JOHANSSON T
    Arterial thrombosis in users of contemporary hormonal contraception.
    BMJ. 2025;388:r237.
    PubMed    


    September 2024
  4. WISE J
    Valproate: Men are advised to use contraception owing to risk of neurodevelopmental disorders in children.
    BMJ. 2024;386:q1957.
    PubMed    


    August 2024
  5. ZENG X, Cheng L, Wu S, Qian X, et al
    Optimising contraceptive services as fertility rates fall in China.
    BMJ. 2024;386:e078642.
    PubMed    


  6. IACOBUCCI G
    Medical abortion: Taking first tablet at home after 12 weeks of pregnancy is safe, study reports.
    BMJ. 2024;386:q1902.
    PubMed    


  7. MAHASE E
    Uterine fibroids: NICE recommends new treatment option for moderate to severe symptoms.
    BMJ. 2024;386:q1805.
    PubMed    


    June 2024
  8. TANNE JH
    Mifepristone: US Supreme Court rejects ban on abortion drug.
    BMJ. 2024;385:q1321.
    PubMed    


  9. TANNE JH
    US Republicans block bill that would have guaranteed access to contraception.
    BMJ. 2024;385:q1251.
    PubMed    


    May 2024
  10. TANNE JH
    US state classifies mifepristone and misoprostol as dangerous controlled substances.
    BMJ. 2024;385:q1175.
    PubMed    


  11. COOPER KG, Bhattacharya S, Daniels JP, Horne AW, et al
    Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial.
    BMJ. 2024;385:e079006.
    PubMed     Abstract available


    March 2024
  12. TANNE JH
    US Supreme Court questions legitimacy of case seeking to ban mifepristone.
    BMJ. 2024;384:q763.
    PubMed    


  13. ROLAND N, Neumann A, Hoisnard L, Duranteau L, et al
    Use of progestogens and the risk of intracranial meningioma: national case-control study.
    BMJ. 2024;384:e078078.
    PubMed     Abstract available


    February 2024
  14. MCNEE R
    Tackling contraceptive misinformation on social media.
    BMJ. 2024;384:q472.
    PubMed    


  15. LOOI MK
    The grey area of "fertility tech" being mis-sold as contraception.
    BMJ. 2024;384:q54.
    PubMed    


    December 2023
  16. WAGNER B, Cleland K
    Retail demand for emergency contraception in United States following New Year holiday: time series study.
    BMJ. 2023;383:e077437.
    PubMed     Abstract available


    November 2023
  17. LIMB M
    Pharmacy health checks and contraceptive service could save 10 million GP appointments.
    BMJ. 2023;383:p2722.
    PubMed    


    September 2023
  18. MEAIDI A
    Filling in the gaps in our understanding of hormonal contraception.
    BMJ. 2023;382:2043.
    PubMed    


  19. SCHMIDT M
    NSAIDs, hormonal contraception, and venous thromboembolism.
    BMJ. 2023;382:p1990.
    PubMed    


  20. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
    Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
    BMJ. 2023;382:e074450.
    PubMed     Abstract available


    August 2023
  21. TANNE JH
    US federal court upholds limits on abortion drug mifepristone.
    BMJ. 2023;382:1924.
    PubMed    


  22. TANNE JH
    Combining anti-inflammatory drug with the morning after pill boosts effectiveness, study finds.
    BMJ. 2023;382:1920.
    PubMed    


    July 2023
  23. TANNE JH
    FDA approves daily over-the-counter oral contraceptive with no age restrictions.
    BMJ. 2023;382:p1631.
    PubMed    


    April 2023
  24. TANNE JH
    US Supreme Court allows mifepristone to remain available for now.
    BMJ. 2023;381:p923.
    PubMed    


  25. MCNALLY S
    Scarlett McNally: Let's talk about contraception.
    BMJ. 2023;381:p862.
    PubMed    


  26. TANNE JH
    Mifepristone remains available in US until midnight on 19 April.
    BMJ. 2023;381:864.
    PubMed    


  27. TANNE JH
    Opposing rulings on mifepristone in US leave access to medical abortion in jeopardy.
    BMJ. 2023;381:822.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.